Valeant trumps Endo with $11 billion bid for Salix Pharma

(Reuters) - Valeant Pharmaceuticals International Inc increased its takeover offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, bumping out Endo International Plc , the only...